Supplementary Data from Syk Inhibition Reprograms Tumor-Associated Macrophages and Overcomes Gemcitabine-Induced Immunosuppression in Pancreatic Ductal Adenocarcinoma
Fields of Study & Subjects
Immune cells in cancer
Pancreatic and Hepatic Oncology Research
Cancer Immunotherapy and Biomarkers
Publication details
- Publication date
- 19 January 2026